Characterization of CD30/CD30L+ Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Barbieri, Alessandro ^a   Dolcino, Marzia ^b   Tinazzi, Elisa ^a   Rigo, Antonella ^a   Argentino, Giuseppe ^a   Patuzzo, Giuseppe ^a   Ottria, Andrea ^c   Beri, Ruggero ^a   Puccetti, Antonio ^b,c   Lunardi, Claudio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD30 LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TNFSF8 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD; CD30+ T LYMPHOCYTE; CD30L+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; IMMUNOLOGY; INFLAMMATION; REGULATORY T LYMPHOCYTE; TH17 CELL;

ANTIGENS, CD30; ARTHRITIS, RHEUMATOID; CD30 LIGAND; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHILS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84930945872     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/729654     Document Type: Article

References (37)

1. C. A. Smith, "CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF," Cell, vol. 73, no. 7, pp. 1349-1360, 1993.
2. H.-J. Gruss, J. Duyster, and F. Herrmann, "Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease," Annals of Oncology, vol. 7, supplement 4, pp. S19-S26, 1996.
3. A. I. Berro, G. A. Perry, and D. K. Agrawal, "Increased expression and activation of CD30 induce apoptosis in human blood eosinophils," Journal of Immunology, vol. 173, no. 3, pp. 2174-2183, 2004.
4. B. Agrawal, M. Reddish, and B. M. Longenecker, "CD30 expression on human CD8+ T-cells isolated from peripheral blood lymphocytes of normal donors," Journal of Immunology, vol. 157, no. 8, pp. 3229-3234, 1996.
5. S. Romagnani, F. Annunziato, R. Manetti et al., "Role for CD30 in HIV expression," Immunology Letters, vol. 51, no. 1-2, pp. 83-88, 1996.
6. V. Gattei, M. Degan, A. Gloghini et al., "CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin," Blood, vol. 89, no. 6, pp. 2048-2059, 1997.
7. H.-J. Gruss, N. Boiani, D. E. Williams, R. J. Armitage, C. A. Smith, and R. G. Goodwin, "Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines,"Blood, vol. 83, no. 8, pp. 2045-2056, 1994.
8. H.-J. Gruss, N. Dasilva, Z.-B. Hu, C. C. Uphoff, R. G. Goodwin, and H. G. Drexler, "Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines," Leukemia, vol. 8, no. 12, pp. 2083-2094, 1994.
9. L. P. Nicod and P. Isler, "Alveolar macrophages in sarcoido-siscoexpress high levels of CD86 (B7.2), CD40 and CD30L,"American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 1, pp. 91-96, 1997.
10. A. Pinto, D. Aldinucci, A. Gloghini et al., "Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line," Blood, vol. 88, no. 9, pp. 3299-3305, 1996.
11. K. D. Shanebeck, C. R. Maliszewski, M. K. Kennedy et al., "Regulation of murine B cell growth and differentiation by CD30 ligand," European Journal of Immunology, vol. 25, no. 8, pp. 2147-2153, 1995.
12. S. R. Wiley, R. G. Goodwin, and C. A. Smith, "Reverse signaling via CD30 ligand," Journal of Immunology, vol. 157, no. 8, pp. 3635-3639, 1996.
13. A. Younes, U. Consoli, S. Zhao et al., "CD30 ligand is expressed on resting normal and malignant human B lymphocytes,"British Journal of Haematology, vol. 93, no. 3, pp. 569-571, 1996.
14. D. Molin, M. Fischer, Z. Xiang et al., "Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease," British Journal of Haematology, vol. 114, no. 3, pp. 616-623, 2001.
15. +T cells," Immunology Letters, vol. 161, no. 2, pp. 236-240, 2014.
16. + T cells producing Th2-type cytokines," The FASEB Journal, vol. 9, no. 1, pp. 81-86, 1995.
17. R. Gerli, C. Lunardi, F. Vinante, O. Bistoni, G. Pizzolo, and C. Pitzalis, "Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases," Trends in Immunology, vol. 22, no. 2, pp. 72-77, 2001.
18. A. Bengtsson, "The role of CD30 in atopic disease," Allergy, vol. 56, no. 7, pp. 593-603, 2001.
19. T. Polte, A.-K. Behrendt, and G. Hansen, "Direct evidence for a critical role of CD30 in the development of allergic asthma,"Journal of Allergy and Clinical Immunology, vol. 118, no. 4, pp. 942-948, 2006.
20. M. Saraiva, P. Smith, P. G. Fallon, and A. Alcami, "Inhibition of type I cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus," The Journal of Experimental Medicine, vol. 196, no. 6, pp. 829-839, 2002.
21. C. Tang, H. Yamada, K. Shibata et al., "A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection," The Journal of Immunology, vol. 181, no. 9, pp. 6316-6327, 2008.
22. Y. Guo, X. Sun, K. Shibata et al., "CD30 is required for activation of a unique subset of interleukin- 17A-Producing γδT Cells in innate immunity against Mycobacterium bovis bacillus calmette-guérin infection," Infection and Immunity, vol. 81, no. 10, pp. 3923-3934, 2013.
23. + T cell function but not expansion,"Nature Immunology, vol. 3, no. 12, pp. 1208-1213, 2002.
24. + T cells via a CD30-dependent mechanism," The Journal of Clinical Investigation, vol. 113, no. 2, pp. 310-317, 2004.
25. F. M. C. Gaspal, M.-Y. Kim, F. M. McConnell, C. Raykundalia, V. Bekiaris, and P. J. L. Lane, "Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory," The Journal of Immunology, vol. 174, no. 7, pp. 3891-3896, 2005.
26. + regulatory T cells in prevention of acute graft-versus-host disease," Blood, vol. 109, no. 5, pp. 2225-2233, 2007.
27. + T cell involvement in the inflamed joints,"Clinical and Experimental Immunology, vol. 102, no. 3, pp. 547-550, 1995.
28. + T cells in rheumatoid synovitis: mechanisms of recruitment and functional role,"Journal of Immunology, vol. 164, no. 8, pp. 4399-4407, 2000.
29. R. Gerli, O. Bistoni, C. Lunardi et al., "Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy," Rheumatology, vol. 38, no. 12, pp. 1282-1284, 1999.
30. R. Gerli, C. Lunardi, E. B. Bocci et al., "Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30," The Journal of Rheumatology, vol. 35, no. 1, pp. 14-19, 2008.
31. P. Miossec, "Are T cells in rheumatoid synovium aggressors or bystanders?" Current Opinion in Rheumatology, vol. 12, no. 3, pp. 181-185, 2000.
32. T. T. Aarvak, M. Chabaud, E. Källberg, P. Miossecdagger, and J. B. Natvig, "Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium," Scandinavian Journal of Immunology, vol. 50, no. 1, pp. 1-9, 1999.
33. + T Cells by IL-4 and IFN-γ," The Journal of Immunology, vol. 158, no. 5, pp. 2090-2098, 1997.
34. P. Pellegrini, A. M. Berghella, I. Contasta, and D. Adorno, "CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response," Transplant Immunology, vol. 12, no. 1, pp. 49-61, 2003.
35. X. Sun, S. Somada, K. Shibata et al., "A critical role of CD30 ligand/CD30 in controlling inflammatory bowel disease in mice," Gastroenterology, vol. 134, no. 2, pp. 447.e3-458.e3, 2008.
36. X. Sun, H. Yamada, K. Shibata et al., "CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice," Journal of Immunology, vol. 185, no. 4, pp. 2222-2230, 2010.
37. D. Aletaha, T. Neogi, A. J. Silman et al., "2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative," Arthritis & Rheumatology, vol. 62, no. 9, pp. 2569-2581, 2010.